Safety Beyond Needlestick Prevention: Making Safety Safer(SM)

Welcome to the Safety Beyond Needlestick Prevention Learning Center

Since the implementation of the Needlestick Safety and Prevention Act in November, 2000, we have come a long way in protecting healthcare workers from sharps injuries. However, mucocutaneous related blood exposure continues to occur and be accepted as "part of the job."

The OSHA Bloodborne Pathogen (BBP) standard is inclusive of blood exposure from all sources, including sharps and mucocutaneous exposures. Recent studies show that blood leakage occurs at a rate of 40-50% during IV conventional catheter insertion.1,3 Another study by Jagger et al. found the at-risk mucocutaneous exposure (MCE) during IV catheter insertions is 128 per 100,000 insertions compared to needlestick injury (NSI) rates of 6.6 per 100,000 conventional devices and 0.7 per 100,000 safety devices.2

Advances in safety engineered peripheral IV catheters now incorporate technology to help protect healthcare workers from both sharps and mucocutaneous blood exposure. The combination of advanced products and work practice control (use of personal protective equipment) can help minimize clinician risk.

This Doesn't Have to Be Part of the Job



Learn more about BD


Safety Solutions
Request Information

BD Safety Technologies

Advances in blood control technology in short peripheral IV catheters help protect clinicians from sharps and mucocutaneous blood exposure. This technology is part of the BD family of IV catheter products that reflect a continuing commitment to meeting HCW safety needs worldwide.

BD Insyte™ Autoguard™ BC Shielded IV Catheter with Blood Control Technology has been shown in a clinical study to reduce the risk of blood exposure compared to a standard non-blood control IV catheter.1

The BD Nexiva™ Closed IV Catheter System all-in-one closed IV catheter system has been shown in a clinical study to provide effective stabilization, and when used with the 3M Tegaderm IV transparent film dressing with border, BD Nexiva is less costly than a standard IV catheter with a StatLock device.4

BD Nexiva™ Diffusics™ Closed IV Catheter System for Radiographic Power Injection is built on the BD Nexiva design and features laser-cut tear-drop shape holes in the catheter tip and allows the use of smaller IV gauge sizes (22 G & 24 G) for power injection.


Clinical Literature

  • Evaluation Of A New Safety Peripheral IV Catheter Designed To Reduce Mucocutaneous Blood Exposure By Rudy Onia, Ingrid Eshun-Wilson, Christina Arce, et al.
  • A Randomized Controlled Trial to Compare the Complications of 2 Peripheral Intravenous Catheter-Stabilization Systems By Dawn Bausone-Gazda, BSN, RN; Cheryl A. Lefaiver, PhD, RN; and Shelley-Ann Walters, MS
  • Risk Factors for Infusion-Related Phlebitis with Small Peripheral Venous Catheters. A Randomized Controlled Study By Dennis G. Maki, MD and Marilyn Ringer, BSN, MS
  • Needlestick Injury Rates According to Different Types of Safety-Engineered Devices: Results of a French Multicenter Study By William Tosini, MD; Ce´line Ciotti, RN; Floriane Goyer, RN, et al.
Request Articles
Quick Compare (chart)
  1. Onia R, Eshun-Wilson I, Arce C, et al. Evaluation of a new safety peripheral IV catheter designed to reduce muccocutaneous blood exposure. Curr Med Res Opin. 2011; 27(7)1339-1346.
  2. Jagger J, Perry J, Perker G, et al. Blood exposure risk during peripheral I.V. Catheter insertion and removal. Nursing. 2011;41(12):45-49.
  3. Richardson D, Kaufman L. Reducing blood exposure risks and costs associated with SPIVC insertion. Nursing Management. 2011;42(12):31-34.
  4. Bausone-Gazda D, Lefaiver CA, Walters SA. A randomized controlled trial to compare the complications of 2 peripheral intravenous catheter-stabilization systems. J Infus Nurs. 2010;33(6)371-384.
Close